Sarepta therapeutics announces inducement grants under nasdaq listing rule 5635(c)(4)

Cambridge, mass., may 28, 2021 (globe newswire) -- sarepta therapeutics, inc. (nasdaq:srpt), the leader in precision genetic medicine for rare diseases, granted equity awards on may 28, 2021 that were previously approved by the compensation committee of its board of directors under sarepta's 2014 employment commencement incentive plan, as a material inducement to employment to 6 individuals hired by sarepta in may 2021. the equity awards were approved in accordance with nasdaq listing rule 5635(c)(4).
SRPT Ratings Summary
SRPT Quant Ranking